The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Telmisartan/Hydrochlorothiazide Rowa 40 mg/12.5 mg tablets

40 mg/12.5 milligram(s) Tablet

Rowa Pharmaceuticals LimitedPA0074/081/001

Main Information

Trade NameTelmisartan/Hydrochlorothiazide Rowa 40 mg/12.5 mg tablets
Active SubstancesHydrochlorothiazide
Telmisartan
Strength40 mg/12.5 milligram(s)
Dosage FormTablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/081/001

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA07 telmisartan and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued04/04/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0050-099-039
Interchangeable List DocumentPDF of Interchangeable List
« Back